Cargando…
Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine
Our understanding of cystic fibrosis (CF) has grown exponentially since the discovery of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in 1989. With evolving genetic and genomic tools, we have come to better understand the role of CFTR genotypes in the pathophysiology of the di...
Autores principales: | Sepahzad, Afsoon, Morris-Rosendahl, Deborah J., Davies, Jane C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069009/ https://www.ncbi.nlm.nih.gov/pubmed/33924524 http://dx.doi.org/10.3390/genes12040562 |
Ejemplares similares
-
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
por: Lopes-Pacheco, Miquéias
Publicado: (2020) -
Gene therapy for cystic fibrosis: new tools for precision medicine
por: Lee, Jin-A, et al.
Publicado: (2021) -
Lung Transplantation in a New Era in the Field of Cystic Fibrosis
por: Huang, Wei, et al.
Publicado: (2023) -
Personalized or Precision Medicine? The Example of Cystic Fibrosis
por: Marson, Fernando A. L., et al.
Publicado: (2017) -
Precision Medicine: The new era in medicine
por: Twilt, Marinka
Publicado: (2016)